Skip to main content

Month: April 2021

Søren Krogh Knudsen appointed new CEO of Columbus

Company announcement no. 20/2021          April 23rd, 2021Søren Krogh Knudsen appointed new CEO of ColumbusCompany announcement Søren Krogh Knudsen will take up the position as President & CEO of Columbus. Søren joins from a position as Partner and Regional Head of PA Consulting Group in the Nordics as well as Global Head of Sales for PA Consulting Group. He is an experienced international leader within the management consultancy industry and has a very strong track record. Columbus’ Board of Directors has appointed Søren Krogh Knudsen as President & CEO of Columbus. Søren Krogh Knudsen will succeed Hans Henrik Thrane in his role as interim CEO since 27 August 2020. Hans Henrik Thrane will continue in his role as Corporate CFO in Columbus.    “Søren Krogh Knudsen is an experienced international leader within the management...

Continue reading

TAAT™ Launches Beyond Nicotine™ Initiative in Light of Impending Federal Anti-Nicotine Regulations to Drive Awareness of TAAT™ Nicotine-Free Alternatives to Tobacco Cigarettes

LAS VEGAS and VANCOUVER, British Columbia, April 23, 2021 (GLOBE NEWSWIRE) — TAAT™ LIFESTYLE & WELLNESS LTD. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) (the “Company” or “TAAT™”) has launched its “Beyond Nicotine™” initiative with an objective of emphasizing the absence of nicotine in its flagship product TAAT™, which is formulated to taste and smell similarly to tobacco despite containing no actual tobacco. On Monday, April 19, 2021, the Wall Street Journal published a report that the Biden administration in the United States is considering enacting a requirement for tobacco companies to reduce nicotine levels in all cigarettes sold nationwide to a level at which they would no longer be addictive1. According to a CNBC report later that day, which covered the apparent negative impact of this announcement on the stock prices...

Continue reading

Enjoy Low Interest Hero FinCorp SME Loan

An an entrepreneur, you have dreams and aspirations to grow the business and you can only achieve the goal with access to funds. Small and medium enterprises are always looking for funds to take the business to new heights. The one thing that is common amongst all SMEs is the need for funds. If you are looking for funds, contact Hero FinCorp. The reliable financial institution offers low-interest Hero FinCorp SME loan in India. The lender is one of the most trusted and has a strong presence across the length and breadth of the country. Hero FinCorp aims to help individuals turn their dreams into a reality. No matter the industry you operate in, you can apply for an SME loan. The loan is available for all size and types of businesses in the industry. In order to apply for the loan, you need to have a profit generating business. You can...

Continue reading

MGI Worldwide Helps Accounting Firms Get Bigger, Better, And Different

Taking pride in its strong international presence and a growing community, MGI Worldwide is considered a leading global accounting network, a platform that helps accounting firms get bigger, better, and stand out among their competitors. More Than 70 Years of Accounting Excellence Since MGI Worldwide established its first international partnership (with Ghana Cocoa Marketing Board) in 1947, the London-based company has been non-stop providing accounting services to more businesses and organisations across the globe. With CPA Associates International members, the accountancy network provides accounting, auditing, tax, and consulting services through its 10,000 professionals in over 100 countries. Their services, which enable business sectors to manage their finances better, also include specialist services such as forensic accountancy,...

Continue reading

After two straight days decline Major Indices rallied and ended higher with Nasdaq leading

The continuous losses were attributed to the fear of investors towards COVID-19 resurgence. With that out of the way, what’s left is the concerns over possibility of increase in consumer market pricing as well as company input costs. The Dow Jones Industrial Average and the S&P 500 Index both managed to reverse earlier losses and converted them into gains. The Dow stepped up by more than 300 points or almost 1%, while S&P moved forward with less than 40 points increase or 0.93%. NASDAQ Composite Index, on the other hand, went against the odds gaining over 160 points or 1.12% despite Netflix losing over 7% after the print on their first quarter gains were released. Netflix reported that their gains were lower than expected for Q1 of 2021. Below is the brief rundown of the market’s movement; – NASDAQ Composite...

Continue reading

Stocks declined as market wraps, S&P and the Dow pulled back from record levels

Investors are staying low-key and are waiting for the reports from the blue chip companies coming out later this week. Since the Dow and S&P hit record levels last week, investors await for the fine print for valuation assurance. These reports will indicate the reflect the much awaited economic revival and will show if they met expectations or not. As for the major index futures, the Dow, S&P, and NASDAQ futures all stayed above the green line ranging from 0.10% to less than 0.20%, which reflects the capability to recover some loses on the next session. Today, all three indexes suffered loses with S&P and the Dow pulling back from the records they had last Friday. The Dow Jones Industrial Average lost more than 120 points or 0.36% closing at 34,078. This ended the Dow’s three-day winning streak, but is still considered...

Continue reading

Stock Market wraps up mixed after news on delayed vaccine rollout

The joint announcement of U.S. Food and Drug Administration along with the Centers for Disease Control and Prevention on pre-market session heavily impacted JNJ’s performance which also hit the Dow. Concerns were raised as the vaccine rollout pause might affect timelines set for the distribution causing delay in the intended goal of herd immunity in the U.S. However, with other suppliers such as Pfizer Inc. and Moderna Inc. around, some still believe that vaccine supply will be enough. According to the reports from health agencies, more than 6 severe blood clots are being investigated closely out of the 6.8 million doses that have been administered so far. The decision was based on ‘abundance of caution’, says FDA on a post in Twitter. S&P 500 closed an all new high today despite the news about the vaccine rollout pause. Continuous...

Continue reading

Yara delivers improved returns with continued premium product growth

Oslo, 23 April 2021: Yara reports improved first-quarter results, as improved pricing more than offset the impact of higher energy cost. First-quarter net income was USD 14 million (USD 0.05 per share) compared with USD –119 million (USD –0.43 per share) a year earlier. The main elements of the first-quarter results are:EBITDA excl. special items1 was USD 585 million, up from 504 million a year earlier, as improved pricing more than offset higher natural gas cost Continued premium product growth USD 2.7 billion free cash flow2 the last 12 months 8.6% ROIC3, up from 6.9% a year earlier“Yara delivers its eleventh consecutive quarter with improved capital returns, with EBITDA excluding special items up 16%, and continued growth in premium sales. The Yara organization continues to perform well in a demanding environment,”...

Continue reading

Yara leverer økt avkastning og fortsatt vekst i premiumprodukter

Oslo, 23. april 2021: Yara rapporterer økte resultater i første kvartal, ettersom økte priser mer enn utlignet høyere energikostnader. Nettoresultatet for første kvartal var på USD 14 millioner (USD 0,05 per aksje) sammenlignet med USD -119 millioner (USD –0,43 per aksje) ett år tidligere. Hovedelementene i resultatet for første kvartal er:EBITDA eksklusive spesielle poster1 var USD 585 millioner, opp fra USD 504 millioner ett år tidligere, ettersom økte priser mer enn utlignet høyere energikostnader Fortsatt vekst i premiumprodukter USD 2,7 milliarder i fri kontantstrøm2 de siste 12 måneder 8,6 % ROIC3, opp fra 6,9% et år tidligere«Yara leverer sitt ellevte kvartal med økt kapitalavkastning, med EBITDA eksklusive spesielle poster opp 16 %, og fortsatt vekst i leveranser av premiumprodukter. Yaras organisasjon fortsetter å levere...

Continue reading

KALLELSE TILL ÅRSSTÄMMA I DLABORATORY SWEDEN AB (PUBL)  

Aktieägarna i Dlaboratory Sweden AB (publ), org.nr 556829-7013, kallas till årsstämma den 27 maj 2021. Mot bakgrund av den extraordinära situation som råder till följd av covid-19-pandemin kommer Dlaboratory Sweden AB:s årsstämma att genomföras genom förhandsröstning (poströstning) med stöd av tillfälliga lagregler. Någon stämma med möjlighet att närvara personligen eller genom ombud kommer inte att äga rum. Dlaboratory Sweden AB välkomnar alla aktieägare att utnyttja sin rösträtt vid årsstämman genom förhandsröstning i den ordning som beskrivs nedan. Information om de vid årsstämman fattade besluten offentliggörs den 27 maj 2021 så snart utfallet av röstningen är slutligt sammanställt. Aktieägare kan i förhandsröstningsformuläret begära att beslut i något eller några av ärendena på den föreslagna dagordningen nedan ska anstå till en...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.